Altrius Capital Management Inc Has $4.45 Million Holdings in Cardinal Health, Inc. (NYSE:CAH)

Altrius Capital Management Inc lessened its stake in Cardinal Health, Inc. (NYSE:CAHFree Report) by 2.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 44,152 shares of the company’s stock after selling 1,337 shares during the quarter. Altrius Capital Management Inc’s holdings in Cardinal Health were worth $4,451,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Cornerstone Planning Group LLC bought a new stake in shares of Cardinal Health in the third quarter worth $26,000. BKM Wealth Management LLC acquired a new stake in shares of Cardinal Health during the 4th quarter worth about $30,000. Wetzel Investment Advisors Inc. acquired a new stake in shares of Cardinal Health during the 4th quarter worth about $36,000. Headlands Technologies LLC bought a new position in Cardinal Health during the third quarter worth about $47,000. Finally, McGlone Suttner Wealth Management Inc. bought a new position in Cardinal Health in the 4th quarter valued at about $59,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.3 %

CAH stock traded down $0.30 during trading on Monday, reaching $102.91. The stock had a trading volume of 1,584,584 shares, compared to its average volume of 2,247,354. Cardinal Health, Inc. has a 52 week low of $77.56 and a 52 week high of $116.04. The stock’s 50 day moving average is $109.51 and its two-hundred day moving average is $104.85. The firm has a market cap of $25.03 billion, a PE ratio of 40.46, a PEG ratio of 1.04 and a beta of 0.68.

Cardinal Health (NYSE:CAHGet Free Report) last issued its earnings results on Thursday, February 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.26. The company had revenue of $57.45 billion for the quarter, compared to the consensus estimate of $57.02 billion. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The firm’s quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter last year, the company earned $1.32 EPS. On average, research analysts anticipate that Cardinal Health, Inc. will post 7.28 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were issued a $0.5006 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.95%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s dividend payout ratio (DPR) is 78.74%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday, April 24th. Barclays assumed coverage on shares of Cardinal Health in a research report on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price target on the stock. Leerink Partnrs restated an “outperform” rating on shares of Cardinal Health in a research report on Monday, February 26th. Argus upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating in a research report on Friday, February 9th. Finally, UBS Group boosted their target price on shares of Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, February 5th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and an average target price of $102.93.

Get Our Latest Stock Report on Cardinal Health

Cardinal Health Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Read More

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.